How much does a box of Vigabatrin Hong Kong version cost?
Vigabatrin is an anti-epileptic drug used to treat refractory epilepsy, especially infantile spasms (West syndrome). The disease usually occurs within a few months of birth and manifests as brief muscle twitching and loss of consciousness. If left untreated, it can lead to severe cognitive and developmental disabilities. Therefore, early and effective treatment is very important to improve patient prognosis.
The main mechanism of action of Vigabatrin is to increase the concentration of GABA in the brain by inhibiting γ-aminobutyric acid (GABA) aminotransferase. GABA is an important inhibitory neurotransmitter that can reduce the overexcitation of neurons, thereby reducing the frequency and severity of epileptic seizures. This makes Vigabatrin a new treatment option in many cases where traditional anti-epileptic drugs are ineffective.

In terms of usage, Vigabatrin is usually taken as an oral powder, and the patient's dosage is adjusted based on the patient's weight and condition. For infantile spasms, doctors will start with a lower dose and gradually increase it to an appropriate therapeutic level to ensure the drug's effectiveness and minimize side effects. When used for a long time, attention should be paid to possible side effects, including drowsiness, fatigue, and visual field defects.
As for the price of the Hong Kong version, the specification of Vigabatrin’s original drug in Hong Kong is500mg*100bags, and the price is about more than 1,000 yuan. This price is cost-effective compared with products of the same specification in the domestic market, and it also provides more choices for patients who need this drug.
In short, Vigabatrin, as an effective anti-epileptic drug, is particularly suitable for patients with refractory epilepsy. Its listing in Hong Kong is priced reasonably and provides patients with a good treatment option. During use, patients should regularly monitor their health status under the guidance of a doctor to ensure the safety and effectiveness of the medication.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)